InvestorsHub Logo
Followers 22
Posts 888
Boards Moderated 0
Alias Born 05/09/2012

Re: None

Tuesday, 09/30/2014 9:14:47 AM

Tuesday, September 30, 2014 9:14:47 AM

Post# of 8169
The share price here is starting to look very attractive for what I perceive to be a future blockbuster cancer treatment. Granted, they still haven't entered their P2 trials yet for cancer treatment but the results to date show unconditionally that their treatment is highly selective in targeting cancer cells,so much so that even cancer STEM cells are targeted as well. I do find it strange that they selected Multiple Myeloma for the P2 trial but I'm sure they have a good reason for it and hopefully saw great pre-clinical efficacy in an animal model...haven't bothered to send an email to IR requesting an explanation though
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CLRB News